Georgetown University

Futó vizsgálatok

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Forrás

• Toboroz

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· 3. fázis· Forrás

• Toboroz

  A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

  NCT07188896· 2. fázis· Forrás

• Toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· 3. fázis· Forrás

• Toboroz

  A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT07154290· 2. fázis· Forrás

• Toboroz

  A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

  NCT07128199· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· 3. fázis· Forrás

• Toboroz

  Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

  NCT07095465· 3. fázis· Forrás

• Toboroz

  Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients

  NCT06853925· Forrás

• Toboroz

  Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

  NCT07029581· 2. fázis· Forrás

• Toboroz

  Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  NCT06943755· 2/3. fázis· Forrás

• Toboroz

  Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

  NCT06950385· 3. fázis· Forrás

• Toboroz

  Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  NCT06808984· 2. fázis· Forrás

• Toboroz

  The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

  NCT06892275· Forrás

• Toboroz

  Mosaic Trial for Stem Cell Transplant Recipients

  NCT06960993· Forrás

• Fut, nem toboroz

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· 3. fázis· Forrás

• Toboroz

  ASSESS ALL ALS Study

  NCT06578195· Forrás

• Toboroz

  Gilteritinib for the Treatment of ALK NSCLC

  NCT06225427· 1. fázis· Forrás

• Fut, nem toboroz

  PREVENT ALL ALS Study

  NCT06581861· Forrás

• Toboroz

  Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

  NCT05655325· Forrás

• Fut, nem toboroz

  A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

  NCT06285643· 2. fázis· Forrás

• Toboroz

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  NCT06112314· 3. fázis· Forrás

• Fut, nem toboroz

  TheraSphere With Durvalumab and Tremelimumab for HCC

  NCT05063565· 2. fázis· Forrás

• Toboroz

  A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  NCT06084936· 3. fázis· Forrás

• Meghívásos bevonás

  Alzheimer's Plasma Extension

  NCT06416072· Forrás

• Fut, nem toboroz

  The BD Liverty™ TIPS Stent Graft Study

  NCT05711316· Forrás

• Toboroz

  Lupus Landmark Study: A Prospective Registry and Biorepository

  NCT05934149· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

  NCT05531656· 2. fázis· Forrás

• Meghívásos bevonás

  Alzheimer's Disease Neuroimaging Initiative 4

  NCT05617014· Forrás

• Toboroz

  Clinical Trial of Approaches to Prostate Cancer Surgery

  NCT05155501· Forrás

• Fut, nem toboroz

  GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

  NCT05686551· 2. fázis· Forrás

• Fut, nem toboroz

  Emicizumab in Patients With Acquired Hemophilia A

  NCT05345197· 2. fázis· Forrás

• Meghívásos bevonás

  Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T

  NCT05529342· Forrás

• Toboroz

  Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

  NCT05098132· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Study of NDI 1150-101 in Patients With Solid Tumors

  NCT05128487· 1/2. fázis· Forrás

• Fut, nem toboroz

  Intervention-Induced Plasticity of Flexibility and Learning Mechanisms in ASD

  NCT05131659· Forrás

• Toboroz

  Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

  NCT04886804· 1. fázis· Forrás

• Toboroz

  Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

  NCT05137665· Forrás

• Fut, nem toboroz

  Metformin in Alzheimer's Dementia Prevention

  NCT04098666· 2/3. fázis· Forrás

• Fut, nem toboroz

  Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

  NCT04624204· 3. fázis· Forrás

• Toboroz

  ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  NCT04398628· Forrás

• Fut, nem toboroz

  AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

  NCT04468659· 3. fázis· Forrás

• Fut, nem toboroz

  HEALEY ALS Platform Trial - Master Protocol

  NCT04297683· 2/3. fázis· Forrás

• Fut, nem toboroz

  Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A

  NCT03932201· Forrás

• Fut, nem toboroz

  Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT03909334· 2. fázis· Forrás

• Fut, nem toboroz

  Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

  NCT03971409· 2. fázis· Forrás

• Fut, nem toboroz

  Spinraza in Adult Spinal Muscular Atrophy

  NCT03709784· Forrás

• Fut, nem toboroz

  Longitudinal Early-onset Alzheimer's Disease Study Protocol

  NCT03507257· Forrás

• Fut, nem toboroz

  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

  NCT03417388· 4. fázis· Forrás

• Toboroz

  HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease

  NCT02855476· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák5 toboroz
• Huntington-kór4 toboroz
• Alzheimer-kór3 toboroz
• Amiotrófiás laterálszklerózis (ALS)2 toboroz
• HIV-fertőzés2 toboroz
• Lewy-testes demencia2 toboroz
• Frontotemporális demencia1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hemofília1 toboroz
• Köpenysejtes limfóma1 toboroz
• Krónikus vesebetegség1 toboroz
• Lupus (SLE)1 toboroz
• Melanóma1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Mielóma multiplex1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pajzsmirigyrák1 toboroz
• Parkinson-kór1 toboroz
• Petefészekrák1 toboroz
• Prosztatarák1 toboroz
• Sarlósejtes vérszegénység1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz
• Thalassaemia1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B

  NCT06611436· 1/2. fázis· Forrás

• Lezárult

  Life's End Benefits of cannaBidiol and tetrahYdrocannabinol

  NCT05644262· 2. fázis· Forrás

• Lezárult

  Healthy Lifestyles: A Home Based Physical Activity Intervention in Persons Living With HIV

  NCT05896852· Forrás

• Leállították

  Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

  NCT05980416· 1. fázis· Forrás

• Leállították

  A Study to Investigate LYL845 in Adults With Solid Tumors

  NCT05573035· 1. fázis· Forrás

• Lezárult

  PositiveLinks: mHealth for DC Cohort

  NCT04998019· Forrás

• Lezárult

  Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

  NCT05287113· 2. fázis· Forrás

• Lezárult

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· 3. fázis· Forrás

• Lezárult

  Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough

  NCT05495243· 2. fázis· Forrás

• Lezárult

  A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

  NCT05924243· 1. fázis· Forrás

• Lezárult

  STEM-Parkinson's Disease

  NCT04797611· Forrás

• Leállították

  A Study to Investigate LYL797 in Adults With Solid Tumors

  NCT05274451· 1. fázis· Forrás

• Leállították

  Next-Gen MS: Feed-forward PRO Data for MS Research

  NCT04907305· Forrás

• Leállították

  Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer

  NCT04849364· 2. fázis· Forrás

• Lezárult

  SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)

  NCT04381468· 1/2. fázis· Forrás

• Lezárult

  PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

  NCT04815876· Forrás

• Leállították

  To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

  NCT04551053· 3. fázis· Forrás

• Leállították

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· 3. fázis· Forrás

• Lezárult

  The MS-LINK™ Outcomes Study

  NCT04735406· Forrás

• Lezárult

  PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy

  NCT04843566· Forrás

• Lezárult

  KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)

  NCT04165083· 2. fázis· Forrás

• Leállították

  Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

  NCT04383210· 2. fázis· Forrás

• Leállították

  A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

  NCT04494256· 1/2. fázis· Forrás

• Lezárult

  Human Epilepsy Project 3

  NCT05374928· Forrás

• Lezárult

  Lu AF28996 in Participants With Parkinson's Disease (PD)

  NCT04291859· 1. fázis· Forrás

• Lezárult

  KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)

  NCT04165096· 2. fázis· Forrás

• Toboroz

  KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

  NCT04165070· 1/2. fázis· Forrás

• Toboroz

  KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

  NCT04165798· Forrás

• Lezárult

  TRC-PAD Program: In-Clinic Trial-Ready Cohort

  NCT04004767· Forrás

• Lezárult

  Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

  NCT03713593· 3. fázis· Forrás

• Leállították

  Study of Entinostat With Nivolumab Plus Ipilimumab in Previously Treated Renal Cell Carcinoma

  NCT03552380· 2. fázis· Forrás

• Lezárult

  Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

  NCT03500328· Forrás

• Lezárult

  A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

  NCT03456063· 3. fázis· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)

  NCT03221426· 3. fázis· Forrás

• Lezárult

  Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

  NCT03586297· Forrás

• Lezárult

  Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

  NCT03117309· 2. fázis· Forrás

• Lezárult

  Memory Improvement Through Nicotine Dosing (MIND) Study

  NCT02720445· 2. fázis· Forrás

• Lezárult

  Alzheimer's Disease Neuroimaging Initiative 3

  NCT02854033· Forrás

• Lezárult

  A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients

  NCT02017717· 3. fázis· Forrás

Vizsgálati helyszínek

• Georgetown University1 vizsgálat
• Georgetown University1 vizsgálat
• Georgetown University82 vizsgálat
• Georgetown University (Neurology)1 vizsgálat
• Georgetown University School of Medicine2 vizsgálat
• Georgetown University (Site 0015)1 vizsgálat
• Georgetown University (Site 0017)1 vizsgálat
• Georgetown University (Site 0036)4 vizsgálat
• Georgetown University (Site 0594)1 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• HIV-fertőzés120 munka · 4 vizsgálat
• Amiloidózis17 munka · 0 vizsgálat
• Huntington-kór9 munka · 5 vizsgálat
• Pajzsmirigyrák9 munka · 1 vizsgálat